NeOnc Technologies Holdings is trading 5.14% higher at $3.07, but the specific driver remains unclear. - The price has rebounded after several weaker sessions. - October 6 coverage highlighted upcoming FDA discussions for NEO100 and a November 17 meeting concerning NEO212; it does not establish a direct cause for today’s gain. - The broader U.S. market was higher, while biotech-sector context was negative.